Choledochal cyst
Overview
- Congenital cystic dilatation of intra/extrahepatic bile ducts.
- Strong female and East Asian predominance; often presents in childhood, but many adults now picked up on imaging.
Summary
Think “abnormal cystic/fusiform ductal dilatation that communicates with the biliary tree + ↑ malignancy risk”.
Pathogenesis & Clinical
- Often associated with abnormal pancreatobiliary junction → pancreatic reflux into CBD → inflammation, weakness, dilatation.
- Classic (but uncommon) triad: RUQ pain + jaundice + palpable mass.
- Adults: recurrent cholangitis, pancreatitis, stones, or incidental on US/CT/MR.
Imaging
- US: cystic structure in porta hepatis continuous with CBD; look for intrahepatic duct (IHD) dilatation, stones, sludge.
- CT/MR: well-defined fluid lesion following bile; exclude hepatic cyst/pseudocyst/duodenal diverticulum.
- MRCP (exam favourite): best non-invasive anatomy + classification; shows communication with ducts and pancreaticobiliary junction.
Todani Classification
- Type I – Isolated extrahepatic duct dilatation (most common)
- IA: cystic; IB: segmental; IC: fusiform.
- Type II – Saccular diverticulum of CBD.
- Type III – Choledochocele (intraluminal cystic dilatation in duodenal wall).
- Type IV
- IVa: multiple extrahepatic + intrahepatic cysts.
- IVb: multiple extrahepatic cysts only.
- Type V – Caroli disease (intrahepatic only; “central dot sign”).
- With congenital hepatic fibrosis → Caroli syndrome.
Exam / Management Angle
Caution
Markedly ↑ risk of cholangiocarcinoma and gallbladder carcinoma, especially Types I, IV and V; risk persists after drainage-alone surgery.
- Definitive treatment is complete cyst excision with biliary-enteric reconstruction
- Liver resection or transplant for advanced Caroli disease.
- Key differentials for porta hepatis cystic lesion:
- pancreatic pseudocyst
- duodenal diverticulum
- hepatic cyst
- gallbladder duplication
MRCP helps by showing ductal communication pattern.